Flere ramt af hukommelsessygdomme i aldrende samfund

10. januar 2026

Rapporteret af AI

Jo ældre befolkningen bliver, desto flere rammes af hukommelsessygdomme som Alzheimers. Forskningen inden for området skrider dog langsomt frem, og kun omkring halvdelen af de ramte modtager den tilgængelige behandling.

I et debatindlæg i Dagens Nyheter stiller Lisa Magnusson spørgsmålstegn ved, hvor behagelige de sidste leveår virkelig vil blive for mange ældre mennesker. Hun påpeker, at jo længere levetid, desto flere individer rammes af hukommelsessygdomme. På trods af dette skrider forskningen på området langsomt frem.nnnIndlægget slår fast, at kun omkring halvdelen af dem, der lider af Alzheimers, modtager den behandling, der faktisk er tilgængelig. Dette vækker bekymring for, hvordan samfundet møder den stigende udbredelse af disse tilstande. Magnusson fremhæver behovet for bedre støtte og fremskridt inden for sundhedsvæsenet for at sikre en værdig alderdom.nnnStykket blev offentliggjort den 10. januar 2026 og er en del af DN's lederside, der fokuserer på debat og refleksion over samfundsspørgsmål.

Relaterede artikler

Diverse young adults reviewing charts on rising cognitive disabilities in a community setting, illustrating a Neurology study on surges among under-40s due to social and economic factors.

Self-reported cognitive disabilities surge among young U.S. adults

2. november 2025 Rapporteret af AI Billede genereret af AI Faktatjekket

A peer-reviewed Neurology study finds a sharp rise in self-reported cognitive difficulties among U.S. adults from 2013 to 2023, with rates nearly doubling in people under 40 and the steepest increases among lower-income and less-educated groups. Authors point to social and economic factors and call for further study.

Scientists identify new dementia affecting millions of elderly

A recently recognized form of dementia, known as LATE, is reshaping understanding of cognitive decline in the elderly, with rising diagnoses and guidelines for doctors published this year. It is estimated to affect about one-third of people aged 85 or older and 10% of those aged 65 or older, often mistaken for Alzheimer's. Experts emphasize the need for a broader range of treatments for this condition.

Alzheimer's drug trials adopt cancer's multi-target approach

12. december 2025 Rapporteret af AI

Alzheimer's trials are shifting to a multi-target approach inspired by cancer research, even after failures with Novo Nordisk's semaglutide. Only two drugs, Eli Lilly's Kisunla and Eisai and Biogen's Leqembi, are widely approved to slow progression. This evolution treats the brain-wasting disease as a complex system, seeking new ways to halt it amid its global impact.

Sundhed

Study shows young blood slows Alzheimer's in mice

Sundhed

U.S. midlife health declines sharply compared to other nations

Sundhed

Severe infections raise dementia risk in large Finnish study

Speed training cuts dementia risk by 25 percent in trial

A 20-year randomized controlled trial has shown that cognitive speed training, combined with booster sessions, reduces the risk of dementia diagnosis by 25 percent among older adults. The study, involving over 2,800 participants aged 65 and older, focused on a computer-based task requiring quick recall of visual details. While results are promising, experts urge caution due to the study's multiple outcome measures.

Højt kødindtag forbundet med lavere demensrisiko

19. marts 2026 Rapporteret af AI

Et højt kødindtag kan reducere demensrisikoen for ældre mennesker med genetisk disposition for Alzheimers, ifølge en undersøgelse fra Karolinska Institutet. Undersøgelsen fulgte over 2.100 personer i alderen 60 år og derover i op til 15 år. Resultaterne gælder for bærere af specifikke apoe-genvarianter.

New test detects Alzheimer's with a finger prick

European scientists have developed a preliminary method to identify Alzheimer's using a drop of dried blood from a finger, achieving 86% accuracy in detecting amyloid pathology. The study, validated in 337 patients from several countries, is published in Nature Medicine and aims to simplify early diagnosis of this disease affecting over 50 million people worldwide.

500.000 svenskere får sundheds- og livsstilsundersøgelse

29. januar 2026 Rapporteret af AI

500.000 personer i Sverige fra 16 år og opefter vil modtage et brev i de kommende dage med spørgsmål fra Folkhälsomyndigheten om deres sundhed og livsstilsvaner. Den nationale undersøgelse «Hälsa på lika villkor» dækker områder som sikkerhed, stress, kost, alkohol og mere. Formålet er at kortlægge forskelle i velvære mellem forskellige grupper.

mandag d. 16. marts 2026, 03.32

Flere ramt af hukommelsessygdomme i aldrende samfund

Relaterede artikler

Self-reported cognitive disabilities surge among young U.S. adults

Scientists identify new dementia affecting millions of elderly

Alzheimer's drug trials adopt cancer's multi-target approach

Study shows young blood slows Alzheimer's in mice

U.S. midlife health declines sharply compared to other nations

Severe infections raise dementia risk in large Finnish study

Speed training cuts dementia risk by 25 percent in trial

Højt kødindtag forbundet med lavere demensrisiko

New test detects Alzheimer's with a finger prick

500.000 svenskere får sundheds- og livsstilsundersøgelse

Six in ten Dalarna residents worry about palliative care

Primary care centers in Dalarna must improve kidney disease detection

Study links Alzheimer's origins to peripheral inflammation

Sverige mangler 65.600 arbejdere i ældreplejen inden 2033

Blood test forecasts Alzheimer's symptoms years ahead

Air pollution linked to higher Alzheimer's risk in older Americans

Super agers have genetic advantages against Alzheimer's risk

Massive study links accelerating memory loss to widespread brain changes

Digital biomarkers can change dementia tracking: IISc professor

Obesity linked to faster rise in Alzheimer’s blood biomarkers, study finds

Dette websted bruger cookies